Search Results - "Krag, T"

Endurance training : An effective and safe treatment for patients with LGMD2I by SVEEN, M.-L, JEPPESEN, T. D, HAUERSLEV, S, KRAG, T. O, VISSING, J

“…We studied the effect of aerobic training on conditioning in patients with limb-girdle muscular dystrophy type 2I (LGMD2I). Nine patients with LGMD2I cycled…”
Get full text

Effect of treatment with grow factors on muscle pathology in the mdx mouse model of Duchenne muscular dystrophy by Nielsen, T, Pinos, T, Krag, T, Vissing, J

Get full text

No effect of oral sucrose or IV glucose during exercise in phosphorylase b kinase deficiency by Andersen, A.G., Ørngreen, M.C., Raaschou-Pedersen, D.E.T., Borch, J. de Stricker, Løkken, N., Krag, T.O., Petersen, M.B., Vissing, J.

“…•This is the first study of oral sucrose supplementation in this patient group.•Neither oral nor IV-glucose improved exercise tolerance in this patient.•PHK…”
Get full text

Muscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophy by Hauerslev, S., Ørngreen, M. C., Hertz, J. M., Vissing, J., Krag, T. O.

“…Background and Objectives The aim of this study was to investigate whether inflammation and regeneration are prominent in mildly affected muscles of patients…”
Get full text

Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment? by Villarreal-Salazar, M., Santalla, A., Real-Martínez, A., Nogales-Gadea, G., Valenzuela, P.L., Fiuza-Luces, C., Andreu, A.L., Rodríguez-Aguilera, J.C., Martín, M.A., Arenas, J., Vissing, J., Lucia, A., Krag, T.O., Pinós, T.

“…McArdle disease is caused by myophosphorylase deficiency and results in complete inability for muscle glycogen breakdown. A hallmark of this condition is…”
Get full text

New advances in McArdle disease: Characterization of the p.R50X knock-in mouse model and evaluation of new therapeutic approaches by Pinós, T, de Luna, N, Brull, A, Nielsen, T, Krag, T, Vissing, J

Get full text

Molecular, morphological and physiological studies in a mouse model of McArdle disease: Similarities to the human disease by Krag, T, Pinos, T, Nielsen, T, Brull, A, Andreu, A, Vissing, J

Get full text

Short- and long-term effects of endurance training in patients with mitochondrial myopathy by Jeppesen, T. D., Dunø, M., Schwartz, M., Krag, T., Rafiq, J., Wibrand, F., Vissing, J.

“…Background and purpose:  It is unknown whether prolonged training is a safe treatment to alleviate exercise intolerance in patients with mitochondrial DNA…”
Get full text

Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T) by Oestergaard, S T, Stojkovic, T, Dahlqvist, J R, Bouchet-Seraphin, C, Nectoux, J, Leturcq, F, Cossée, M, Solé, G, Thomsen, C, Krag, T O, Vissing, J

“…In this study, muscle involvement assessed by MRI and levels of GMPPB and glycosylation of α-dystroglycan expression in muscle were examined in patients with…”
Get full text

A new mutation of the fukutin gene causing late-onset limb girdle muscular dystrophy by Riisager, M, Duno, M, Hansen, F. Juul, Krag, T.O, Vissing, C.R, Vissing, J

“…Abstract Defects in glycosylations of α-dystroglycan are associated with mutations in several genes, including the fukutin gene ( FKTN ). Hypoglycosylation of…”
Get full text

Muscle regeneration in mitochondrial myopathies by Krag, T O, Hauerslev, S, Jeppesen, T D, Duno, M, Vissing, J

“…Mitochondrial myopathies cover a diverse group of disorders in which ragged red and COX-negative fibers are common findings on muscle morphology. In contrast,…”
Get full text

A possible role of MAP-1 in skeletal muscle regeneration by Munthe-Fog, Lea, Schjerling, P, Skjoedt, Mikkel-Ole, Krag, T, Madsen, H.O, Vissing, J, Kjaer, M, Garred, Peter

Get full text

559P Immunological biomarkers in immune-mediated and hereditary polyneuropathies by Kodal, L., Krag, T., Dysgaard, T.

“…Proinflammatory cytokines, such as interleukin (IL)-8, IL6, and IL10, have been found to be higher in patients with Chronic Inflammatory Demyelinating…”
Get full text

No muscle involvement in myoclonus-dystonia caused by epsilon-sarcoglycan gene mutations by Hjermind, L E, Vissing, J, Asmus, F, Krag, T, Lochmüller, H, Walter, M C, Erdal, J, Blake, D J, Nielsen, J E

“…Mutations in the epsilon-sarcoglycan gene (SGCE) can cause autosomal dominant inherited myoclonus-dystonia (M-D). Defects in other sarcoglycans; alpha-, beta-,…”
Get full text

90-kDa Ribosomal S6 Kinase Is Phosphorylated and Activated by 3-Phosphoinositide-dependent Protein Kinase-1 by Jensen, Claus J., Buch, Maj-Britt, Krag, Thomas O., Hemmings, Brian A., Gammeltoft, Steen, Frödin, Morten

“…90-kDa ribosomal S6 kinase-2 (RSK2) belongs to a family of growth factor-activated serine/threonine kinases composed of two kinase domains connected by a…”
Get full text

Characterization of a glutathione S-transferase and a related glutathione-binding protein from gill of the blue mussel, Mytilus edulis by Fitzpatrick, P J, Krag, T O, Højrup, P, Sheehan, D

“…The major isoenzyme of glutathione S-transferase (GST 1) was purified to homogeneity from cytosolic extracts of Mytilus edulis gill tissue by GSH-agarose…”
Get full text

MYASTHENIA & RELATED DISORDERS by Krag, T., Holm-Yildiz, S., Witting, N., Vissing, J.

Get full text

MYASTHENIA & RELATED DISORDERS: P.37 Autophagy affected in patients with hypokalemic periodic paralysis by Krag, T., Holm-Yildiz, S., Witting, N., Vissing, J.

Get full text

Skeletal muscle involvement in patients with truncations of titin and familial dilated cardiomyopathy by Vissing, C R, Skriver, S V, Krett, B, Poulsen, N S, Krag, T, Walas, H R, Christensen, A H, Bundgaard, H, Vissing, J

“…Abstract Background Variants in TTN are associated with dilated cardiomyopathy (DCM) and skeletal myopathy with or without cardiac affection. However, the…”
Get full text

O.14B3GNT4 deficiency: a new α-dystroglycanopathy causing late-onset progressive brain atrophy and muscular dystrophy by Vissing, J., Töpf, A., Straub, V., Krag, T.

Get full text